← Back to Clinical Trials
RecruitingNCT06773546

Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System Disorders

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionInborn Errors of Immunity
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment400
SexALL
Min AgeN/A
Max Age50 Years
Start Date2023-09-15
Completion2026-06-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is an observational, retro-prospective, moncentric study focused on Inborn Errors of Immunity, an heterogeneous group of inherited diseases due to defects in the differentiation and/or function of the immune system. The primary aim of this study is to obtain a clinical-immunological, functional and molecular characterisation of paediatric and adult patients with confirmed or suspected Inborn Errors of Immunity, particularly of patients with manifestations of immunedysregulation, focusing on clinical course, immunophenotypic laboratory and functional abnormalities, genetic background.

Eligibility Criteria

Inclusion Criteria: * patients with confirmed or suspected Inborn Errors of Immunity; * age \< 50 years at onset of clinical features suspected for Inborn Errors of Immunity; * obtaining informed consent from patients or parents/legal guardian of pediatric patients. Exclusion Criteria: • patients in whom infectious susceptibility and immunodysregulation can only be attributed to known non-immunological causes: acquired immunodeficiency secondary to chronic infections (HIV), and acquired immunodeficiency secondary to immunosuppressive treatment.

Related Trials